| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.3 | 0.1 |